 | Up a level |
Riek, Myriam; Scherer, Almut; Möller, Burkhard; Ciurea, Adrian; von Mühlenen, Ines; Gabay, Cem; Kyburz, Diego; Brulhart, Laure; von Kempis, Johannes; Mueller, Ruediger B; Hasler, Paul; Strahm, Tanja; von Känel, Sabine; Zufferey, Pascal; Dudler, Jean; Finckh, Axel (2023). Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care. Scientific Reports, 13(1), p. 17776. Nature Publishing Group 10.1038/s41598-023-44841-w
Amstad, Andrea; Papagiannoulis, Eleftherios; Scherer, Almut; Rubbert-Roth, Andrea; Finckh, Axel; Mueller, Ruediger; Dudler, Jean; Möller, Burkhard; Villiger, Peter M; Schulz, Martin M P; Kyburz, Diego (2022). Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy. Rheumatology, 62(1), pp. 89-97. Oxford University Press 10.1093/rheumatology/keac285
Ahmanna Chakir, Farah; Folly, Antoine; Dudler, Jean (2021). [Methotrexate use: untangling the real from the fake]. Revue médicale suisse, 17(744-2), pp. 1273-1278. Médecine & Hygiène
Alpizar-Rodriguez, Deshiré; Mueller, Rüdiger B.; Möller, Burkhard; Dudler, Jean; Ciurea, Adrian; Zufferey, Pascal; Kyburz, Diego; Walker, Ulrich A.; von Mühlenen, Ines; Roux-Lombard, Pascale; Mahler, Michael; Lamacchia, Celine; Courvoisier, Delphine S.; Gabay, Cem; Finckh, Axel (2017). Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis. Rheumatology, 56(9), pp. 1579-1585. Oxford University Press 10.1093/rheumatology/kex239
Alpizar-Rodriguez, D; Brulhart, Laure; Mueller, Ruediger B.; Möller, Burkhard; Dudler, Jean; Ciurea, Adrian; Walker, Ulrich A.; Von Mühlenen, Ines; Kyburz, Diego; Zufferey, Pascal; Mahler, Michael; Bas, Sylvette; Gascon, Danielle; Lamacchia, Céline; Roux-Lombard, Pascale; Lauper, Kim; Nissen, Michael J.; Courvoisier, Delphine S.; Gabay, Cem and Finckh, Axel (2017). The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis. Clinical rheumatology, 36(3), pp. 677-682. Springer 10.1007/s10067-017-3547-3
Mueller, Ruediger B; Gengenbacher, Michael; Richter, Symi; Dudler, Jean; Möller, Burkhard; von Kempis, Johannes (2016). Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK). Arthritis research & therapy, 18(88), p. 88. BioMed Central 10.1186/s13075-016-0985-2
Boehncke, Wolf-Henning; Anliker, Mark David; Conrad, Curdin; Dudler, Jean; Hasler, Fritz; Hasler, Paul; Häusermann, Peter; Kyburz, Diego; Laffitte, Emmanuel; Michel, Beat A; Möller, Burkhard; Navarini, Alexander A; Villiger, Peter; Yawalkar, Nikhil; Gabay, Cem (2015). The dermatologists' role in managing psoriatic arthritis: results of a swiss delphi exercise intended to improve collaboration with rheumatologists. Dermatology, 230(1), pp. 75-81. Karger 10.1159/000367688
Finckh, Axel; Möller, Burkhard; Dudler, Jean; Walker, Ulrich A; Kyburz, Diego; Gabay, Cem; physicians of the Swiss Clinical Quality Management for Rheumato, ; physicians of SCQM-RA, (2012). Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists. Annals of the rheumatic diseases, 71(10), pp. 1680-5. London: BMJ Publishing Group 10.1136/annrheumdis-2011-201016
von Kempis, Johannes; Dudler, Jean; Hasler, Paul; Kyburz, Diego; Tyndall, Alan; Zufferey, Pascal; Villiger, Peter M (2012). Use of abatacept in rheumatoid arthritis. Swiss medical weekly, 142, w13581. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2012.13581
Walker, Ulrich A; Courvoisier, Delphine S; Dudler, Jean; Aeberli, Daniel; von Kempis, Johannes; Scherer, Almut; Finckh, Axel; on behalf of the, Swiss Clinical Quality Management Programme in Rheumatic Disease (2011). Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion. Rheumatology, 50(1), pp. 243-244. Oxford: Oxford University Press 10.1093/rheumatology/keq258
Dudler, Jean; Möller, Burkhard; Michel, Beat A; Villiger, Peter M (2011). Biologics in rheumatoid arthritis--recommendations for Swiss practice. Swiss medical weekly, 141, w13189. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13189
Finckh, Axel; Dudler, Jean; Wermelinger, Felix; Ciurea, Adrian; Kyburz, Diego; Gabay, Cem; Bas, Sylvette; physicians of SCQM, (2010). Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients. Joint bone spine, 77(4), pp. 313-8. Paris: Elsevier Masson SAS 10.1016/j.jbspin.2010.02.021
